Evidence map›Paper›PMID 42591965›Full record

ArticleTH open : companion journal to thrombosis and haemostasis2026

Post Hoc Analyses of A-SURE and PREVENT Confirm the Effectiveness of rFVIIIFc Prophylaxis Across All Ages, BMIs, Severities, and Inhibitor Histories.

Johannes Oldenburg, Andreas Tiede, Jayanthi Alamelu, María Teresa Álvarez Román, Christoph Bidlingmaier, Pål Andre Holme, Flora Peyvandi, Eva Bednar, Eveline Nüesch, Stefan Lethagen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in TH open : companion journal to thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Johannes OldenburgInstitute of Experimental Haematology and Transfusion MedicineUniversity Hospital Bonn, Medical Faculty, University of BonnBonnGermany.
Andreas TiedeDepartment of Hematology, Hemostasis, Oncology and Stem Cell TransplantationHannover Medical SchoolHannoverGermany.ORCID 0000-0002-3600-8536
Jayanthi AlameluPaediatric HaematologyEvelina London Children's Hospital, Guy's and St Thomas' NHS Foundation TrustLondonUnited Kingdom of Great Britain and Northern Ireland.
María Teresa Álvarez RománDepartment of HaematologyLa Paz University Hospital-IdiPazMadridSpain.
Christoph BidlingmaierDepartment of PediatricsDr. von Hauner Children's Hospital, Pediatric Hemophilia Center, LMU MunichMunichGermany.
Pål Andre HolmeDepartment of HaematologyOslo University Hospital, Institute of Clinical Medicine, University of OsloOsloNorway.
Flora PeyvandiFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Haemophilia and Thrombosis CentreMilanItaly.
Eva BednarGlobal Medical Affairs and Clinical DevelopmentSobiStockholmSweden.
Eveline NüeschBiometricsSobiBaselSwitzerland.
Stefan LethagenGlobal Medical Affairs and Clinical DevelopmentSobiStockholmSweden.ORCID 0000-0002-8436-1780

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

factor VIIIhemophilia Aprospective studies

Identifiers

PMID42591965
PMCPMC13463922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.